Stock Analysis

3 KRX Growth Companies With Up To 38% Insider Ownership

KOSDAQ:A348370
Source: Shutterstock

Over the last 7 days, the South Korean market has risen 2.2%, while its performance over the past year has been flat. In this environment where earnings are forecast to grow by 29% annually, identifying growth companies with significant insider ownership can provide valuable insights into potential investment opportunities.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.5%35.6%
Seojin SystemLtd (KOSDAQ:A178320)30.5%52.1%
Bioneer (KOSDAQ:A064550)17.5%97.6%
ALTEOGEN (KOSDAQ:A196170)26.6%99.5%
Park Systems (KOSDAQ:A140860)33%35.7%
Vuno (KOSDAQ:A338220)19.5%110.9%
Devsisters (KOSDAQ:A194480)26.2%63%
HANA Micron (KOSDAQ:A067310)18.3%100.3%
INTEKPLUS (KOSDAQ:A064290)16.3%96.7%
Techwing (KOSDAQ:A089030)18.7%83.6%

Click here to see the full list of 78 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biotechnology company specializing in long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩16.97 trillion.

Operations: The company's revenue primarily comes from its biotechnology segment, totaling ₩90.79 billion.

Insider Ownership: 26.6%

ALTEOGEN, a South Korean growth company with high insider ownership, recently received MFDS approval for Tergase®, a recombinant hyaluronidase. This milestone supports its transition to a commercial-stage company. The stock is trading at 75.2% below fair value and is forecast to become profitable in three years with revenues growing at 64.2% per year, significantly outpacing the market average. Despite recent shareholder dilution and share price volatility, earnings are expected to grow by 99.46% annually with very high future return on equity (66.3%).

KOSDAQ:A196170 Ownership Breakdown as at Sep 2024
KOSDAQ:A196170 Ownership Breakdown as at Sep 2024

Enchem (KOSDAQ:A348370)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Enchem Co., Ltd. manufactures and sells electrolytes and additives for secondary batteries and EDLC, with a market cap of ₩3.81 billion.

Operations: Enchem's primary revenue segment is Electronic Components & Parts, generating ₩348.75 million.

Insider Ownership: 19.4%

Enchem, a South Korean company with significant insider ownership, is forecast to become profitable within the next three years, showing annual earnings growth of 155.2%. Revenue is expected to grow at 63% per year, substantially outpacing the market average of 10.1%. However, shareholders have experienced dilution over the past year and the stock has displayed high volatility in recent months. No substantial insider trading activity has been recorded in the last three months.

KOSDAQ:A348370 Ownership Breakdown as at Sep 2024
KOSDAQ:A348370 Ownership Breakdown as at Sep 2024

Doosan (KOSE:A000150)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Doosan Corporation operates in heavy industry, machinery manufacturing, and apartment construction across South Korea, the United States, Asia, the Middle East, Europe, and internationally with a market cap of ₩2.48 trillion.

Operations: The company's revenue segments include Doosan Bobcat (₩9.31 billion), Doosan Energy (₩8.25 billion), Electronic BG (₩855.42 million), Doosan Fuel Cell (₩279.99 million), and Digital Innovation BU (₩286.29 million).

Insider Ownership: 38.9%

Doosan, with substantial insider ownership, is expected to become profitable within three years, showing annual earnings growth of 65.51%. However, its revenue growth forecast of 3.7% per year lags behind the market average of 10.1%. The stock trades at a significant discount to its estimated fair value but has shown high volatility recently. No notable insider trading activity has been recorded in the past three months.

KOSE:A000150 Earnings and Revenue Growth as at Sep 2024
KOSE:A000150 Earnings and Revenue Growth as at Sep 2024

Key Takeaways

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if Enchem might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com